{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:20:27Z","timestamp":1793110827426,"version":"4.5.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 82071686"],"award-info":[{"award-number":["No. 82071686"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"DOI":"10.1186\/s40360-024-00822-x","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T15:20:05Z","timestamp":1734535205000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Data mining in FAERS: association of newer-generation H1-antihistamines with nervous system disorders"],"prefix":"10.1186","volume":"25","author":[{"given":"Weiping","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenghong","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,18]]},"reference":[{"issue":"3","key":"822_CR1","first-page":"44","volume":"16","author":"I Podder","year":"2023","unstructured":"Podder I, Dhabal A, Chakraborty SS. Efficacy and safety of Up-dosed second-generation antihistamines in uncontrolled chronic spontaneous urticaria: a review. J Clin Aesthet Dermatol. 2023;16(3):44\u201350.","journal-title":"J Clin Aesthet Dermatol"},{"issue":"5","key":"822_CR2","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/j.1365-2222.2007.02678.x","volume":"37","author":"RJ Powell","year":"2007","unstructured":"Powell RJ, et al. BSACI guidelines for the management of chronic urticaria and angio-oedema. Clin Exp Allergy. 2007;37(5):631\u201350.","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"822_CR3","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1358\/mf.2008.30.3.1186087","volume":"30","author":"N Izumi","year":"2008","unstructured":"Izumi N, et al. Analysis of disease-dependent sedative profiles of H(1)-antihistamines by large-scale surveillance using the visual analog scale. Methods Find Exp Clin Pharmacol. 2008;30(3):225\u201330.","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"822_CR4","doi-asserted-by":"publisher","first-page":"1322788","DOI":"10.3389\/fphar.2024.1322788","volume":"15","author":"W Liu","year":"2024","unstructured":"Liu W, et al. Model-based exploration of the rationality of off-label use of cetirizine in Chinese pediatric patients: a prospective cohort study. Front Pharmacol. 2024;15:1322788.","journal-title":"Front Pharmacol"},{"issue":"1","key":"822_CR5","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/bcpt.13948","volume":"134","author":"H Nordeng","year":"2024","unstructured":"Nordeng H, et al. Transfer of cetirizine\/levocetirizine into human breast milk and estimation of drug exposure to infants through breastfeeding: a human lactation study from the ConcePTION project. Basic Clin Pharmacol Toxicol. 2024;134(1):153\u201364.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"822_CR6","volume-title":"Drugs and Lactation Database (LactMed\u00ae)","author":"Levocetirizine","year":"2006","unstructured":"Levocetirizine. Drugs and Lactation Database (LactMed\u00ae). National Institute of Child Health and Human Development: Bethesda (MD); 2006."},{"issue":"3","key":"822_CR7","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3109\/13651501.2014.907919","volume":"18","author":"PG Ozdemir","year":"2014","unstructured":"Ozdemir PG, et al. Assessment of the effects of antihistamine drugs on mood, sleep quality, sleepiness, and dream anxiety. Int J Psychiatry Clin Pract. 2014;18(3):161\u20138.","journal-title":"Int J Psychiatry Clin Pract"},{"key":"822_CR8","unstructured":"Carson S, Lee N, Thakurta S. 2010, Drug class reviews, in drug class review: Newer Antihistamines: Final Report Update 2. Oregon Health & Science University. Copyright \u00a9 2010 by Oregon Health & Science University, Portland, Oregon 97239. All rights reserved.: Portland (OR)."},{"issue":"8","key":"822_CR9","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1016\/j.jaip.2023.03.058","volume":"11","author":"W Chaichan","year":"2023","unstructured":"Chaichan W, et al. Comparative safety profiles of individual second-generation H1-Antihistamines for the treatment of Chronic Urticaria: a systematic review and network Meta-analysis of Randomized controlled trials. J Allergy Clin Immunol Pract. 2023;11(8):2365\u201381.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1\u20132","key":"822_CR10","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1046\/j.1440-1681.2003.03791.x","volume":"30","author":"M Nishiga","year":"2003","unstructured":"Nishiga M, et al. Effects of second-generation histamine H1 receptor antagonists on the active avoidance response in rats. Clin Exp Pharmacol Physiol. 2003;30(1\u20132):60\u20133.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"822_CR11","doi-asserted-by":"crossref","unstructured":"Ramos H et al. CRIDECO anticholinergic load scale: an updated anticholinergic Burden Scale. Comparison with the ACB Scale in Spanish individuals with subjective memory complaints. J Pers Med 2022;12(2).","DOI":"10.3390\/jpm12020207"},{"issue":"12","key":"822_CR12","doi-asserted-by":"publisher","first-page":"e114336","DOI":"10.1371\/journal.pone.0114336","volume":"9","author":"T Isomura","year":"2014","unstructured":"Isomura T, et al. Central nervous system effects of the second-generation antihistamines marketed in Japan\u2013review of inter-drug differences using the proportional impairment ratio (PIR). PLoS ONE. 2014;9(12):e114336.","journal-title":"PLoS ONE"},{"issue":"10","key":"822_CR13","doi-asserted-by":"publisher","first-page":"5909","DOI":"10.4103\/jfmpc.jfmpc_77_22","volume":"11","author":"KS Shamil","year":"2022","unstructured":"Shamil KS, et al. Old versus new antihistamines: effects on cognition and psychomotor functions. J Family Med Prim Care. 2022;11(10):5909\u201317.","journal-title":"J Family Med Prim Care"},{"issue":"1","key":"822_CR14","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1046\/j.0022-0477.2001.01245.x","volume":"32","author":"I Hindmarch","year":"2002","unstructured":"Hindmarch I, Shamsi Z, Kimber S. An evaluation of the effects of high-dose fexofenadine on the central nervous system: a double-blind, placebo-controlled study in healthy volunteers. Clin Exp Allergy. 2002;32(1):133\u20139.","journal-title":"Clin Exp Allergy"},{"issue":"10","key":"822_CR15","doi-asserted-by":"publisher","first-page":"897","DOI":"10.2165\/00002018-200629100-00007","volume":"29","author":"D Layton","year":"2006","unstructured":"Layton D, et al. Comparison of the risk of drowsiness and sedation between levocetirizine and desloratadine: a prescription-event monitoring study in England. Drug Saf. 2006;29(10):897\u2013909.","journal-title":"Drug Saf"},{"key":"822_CR16","doi-asserted-by":"crossref","unstructured":"Su CH, et al. Cumulative dose effects of H1 antihistamine use on the risk of dementia in patients with allergic Rhinitis. J Allergy Clin Immunol Pract 2024.","DOI":"10.1016\/j.jaip.2024.05.027"},{"issue":"4","key":"822_CR17","first-page":"407","volume":"57","author":"\u00d6 Y\u0131lmaz-Topa","year":"2015","unstructured":"Y\u0131lmaz-Topa \u00d6, et al. Cetirizine and albendazole induced dystonia in a child. Turk J Pediatr. 2015;57(4):407\u20138.","journal-title":"Turk J Pediatr"},{"issue":"9","key":"822_CR18","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1097\/PEC.0b013e3181850c35","volume":"24","author":"I Esen","year":"2008","unstructured":"Esen I, et al. Cetirizine-induced dystonic reaction in a 6-year-old boy. Pediatr Emerg Care. 2008;24(9):627\u20138.","journal-title":"Pediatr Emerg Care"},{"issue":"1","key":"822_CR19","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1212\/01.wnl.0000191323.58722.38","volume":"66","author":"A Rajput","year":"2006","unstructured":"Rajput A, Baerg K. Cetirizine-induced dystonic movements. Neurology. 2006;66(1):143\u20134.","journal-title":"Neurology"},{"key":"822_CR20","unstructured":"Naqvi A, Patel P, Gerriets V. Cetirizine, in StatPearls. StatPearls Publishing. 2024. Copyright \u00a9 2024, StatPearls Publishing LLC.: Treasure Island (FL) ineligible companies. Disclosure: Preeti Patel declares no relevant financial relationships with ineligible companies. Disclosure: Valerie Gerriets declares no relevant financial relationships with ineligible companies."},{"issue":"9","key":"822_CR21","first-page":"1216","volume":"63","author":"FI Bawany","year":"2013","unstructured":"Bawany FI, et al. Cetirizine: an antihistamine associated with dystonia and oculogyric crises. J Pak Med Assoc. 2013;63(9):1216.","journal-title":"J Pak Med Assoc"},{"issue":"5","key":"822_CR22","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.parkreldis.2014.02.005","volume":"20","author":"MT Pellecchia","year":"2014","unstructured":"Pellecchia MT, et al. Drug induced oromandibular dystonia: a case related to prolonged use of cetirizine. Parkinsonism Relat Disord. 2014;20(5):566\u20137.","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"822_CR23","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0002-9394(03)00869-9","volume":"137","author":"FW Fraunfelder","year":"2004","unstructured":"Fraunfelder FW, Fraunfelder FT. Oculogyric crisis in patients taking cetirizine. Am J Ophthalmol. 2004;137(2):355\u20137.","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"822_CR24","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.ophtha.2003.12.052","volume":"111","author":"FW Fraunfelder","year":"2004","unstructured":"Fraunfelder FW, Fraunfelder FT. Adverse ocular drug reactions recently identified by the national registry of drug-induced ocular side effects. Ophthalmology. 2004;111(7):1275\u20139.","journal-title":"Ophthalmology"},{"issue":"4","key":"822_CR25","doi-asserted-by":"publisher","first-page":"e1068","DOI":"10.1542\/peds.2013-0655","volume":"133","author":"A Biedro\u0142","year":"2014","unstructured":"Biedro\u0142 A, Kaci\u0142ski M, Skowronek-Ba\u0142a B. Stabbing headache in an 8-year-old girl: primary or drug induced headache? Pediatrics. 2014;133(4):e1068\u201371.","journal-title":"Pediatrics"},{"issue":"4","key":"822_CR26","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1055\/s-0033-1333871","volume":"44","author":"C Cerminara","year":"2013","unstructured":"Cerminara C, et al. Seizures induced by desloratadine, a second-generation antihistamine: clinical observations. Neuropediatrics. 2013;44(4):222\u20134.","journal-title":"Neuropediatrics"},{"issue":"2","key":"822_CR27","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.jaci.2007.03.034","volume":"120","author":"S Walker","year":"2007","unstructured":"Walker S, et al. Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: case-control study. J Allergy Clin Immunol. 2007;120(2):381\u20137.","journal-title":"J Allergy Clin Immunol"},{"key":"822_CR28","unstructured":"FDA. FDA Adverse Event Reporting System (FAERS). 2017; https:\/\/www.fda.gov\/drugs\/drug-approvals-and-databases\/fda-adverse-event-reporting-system-faers"},{"issue":"8","key":"822_CR29","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s40264-023-01317-0","volume":"46","author":"F Al-Azzawi","year":"2023","unstructured":"Al-Azzawi F, et al. Developing an Artificial Intelligence-Guided Signal Detection in the Food and Drug Administration adverse event reporting System (FAERS): a proof-of-Concept Study using Galcanezumab and simulated data. Drug Saf. 2023;46(8):743\u201351.","journal-title":"Drug Saf"},{"key":"822_CR30","unstructured":"FDA. https:\/\/www.fda.gov\/drugs\/surveillance\/questions-and-answers-fdas-adverse-event-reporting-system-faers"},{"issue":"2","key":"822_CR31","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1093\/jamia\/ocv063","volume":"23","author":"HJ Duggirala","year":"2015","unstructured":"Duggirala HJ, et al. Use of data mining at the Food and Drug Administration. J Am Med Inform Assoc. 2015;23(2):428\u201334.","journal-title":"J Am Med Inform Assoc"},{"issue":"6","key":"822_CR32","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1007\/s11096-022-01472-x","volume":"44","author":"JJ Chen","year":"2022","unstructured":"Chen JJ, et al. Data mining for adverse drug reaction signals of daptomycin based on real-world data: a disproportionality analysis of the US Food and Drug Administration adverse event reporting system. Int J Clin Pharm. 2022;44(6):1351\u201360.","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"822_CR33","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1177\/0962280211403602","volume":"22","author":"I Zorych","year":"2013","unstructured":"Zorych I, et al. Disproportionality methods for pharmacovigilance in longitudinal observational databases. Stat Methods Med Res. 2013;22(1):39\u201356.","journal-title":"Stat Methods Med Res"},{"key":"822_CR34","doi-asserted-by":"crossref","unstructured":"Shen B. Healthcare+and+Big+Data+Management.pdf 2017:1028.","DOI":"10.1007\/978-981-10-6041-0"},{"issue":"5","key":"822_CR35","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1007\/s00210-023-02796-9","volume":"397","author":"T Specht","year":"2024","unstructured":"Specht T, Seifert R. Repurposing of H(1)-receptor antagonists (levo)cetirizine, (des)loratadine, and fexofenadine as a case study for systematic analysis of trials on clinicaltrials.gov using semi-automated processes with custom-coded software. Naunyn Schmiedebergs Arch Pharmacol. 2024;397(5):2995\u20133018.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"4","key":"822_CR36","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s00482-020-00479-5","volume":"34","author":"ML Schmidbauer","year":"2020","unstructured":"Schmidbauer ML, et al. [Drug-induced reversible cerebral vasoconstriction syndrome: Ustekinumab as possible trigger?]. Schmerz. 2020;34(4):350\u20133.","journal-title":"Schmerz"},{"key":"822_CR37","unstructured":"Nesheiwat O, Al-Khoury L. Reversible cerebral vasoconstriction syndromes, in StatPearls. StatPearls Publishing. 2024. Copyright \u00a9 2024, StatPearls Publishing LLC.: Treasure Island (FL) ineligible companies. Disclosure: Lama Al-Khoury declares no relevant financial relationships with ineligible companies."},{"issue":"4","key":"822_CR38","doi-asserted-by":"publisher","first-page":"180","DOI":"10.4103\/picr.picr_28_23","volume":"14","author":"VV Sinha","year":"2023","unstructured":"Sinha VV, et al. Comparative study of efficacy and safety of cetirizine and bilastine in patients of chronic spontaneous urticaria: Open-label, randomized, parallel-group study. Perspect Clin Res. 2023;14(4):180\u20136.","journal-title":"Perspect Clin Res"},{"issue":"3","key":"822_CR39","doi-asserted-by":"publisher","first-page":"222","DOI":"10.2500\/aap.2017.38.4050","volume":"38","author":"AS Nayak","year":"2017","unstructured":"Nayak AS, et al. Randomized, placebo-controlled study of cetirizine and loratadine in children with seasonal allergic rhinitis. Allergy Asthma Proc. 2017;38(3):222\u201330.","journal-title":"Allergy Asthma Proc"},{"key":"822_CR40","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.neuroscience.2024.03.032","volume":"546","author":"J Tan","year":"2024","unstructured":"Tan J, et al. Therapeutic potential of natural compounds in Subarachnoid Haemorrhage. Neuroscience. 2024;546:118\u201342.","journal-title":"Neuroscience"},{"issue":"6","key":"822_CR41","doi-asserted-by":"publisher","first-page":"103113","DOI":"10.1016\/j.amjoto.2021.103113","volume":"42","author":"JV Bernichi","year":"2021","unstructured":"Bernichi JV, et al. Rhinogenic and sinus headache - literature review. Am J Otolaryngol. 2021;42(6):103113.","journal-title":"Am J Otolaryngol"},{"issue":"1","key":"822_CR42","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s40360-019-0363-1","volume":"20","author":"CZ Huang","year":"2019","unstructured":"Huang CZ, et al. Antihistamine effects and safety of fexofenadine: a systematic review and Meta-analysis of randomized controlled trials. BMC Pharmacol Toxicol. 2019;20(1):72.","journal-title":"BMC Pharmacol Toxicol"},{"issue":"10","key":"822_CR43","first-page":"866","volume":"331","author":"JA Bernstein","year":"2024","unstructured":"Bernstein JA, et al. Allergic Rhinitis: Rev Jama. 2024;331(10):866\u201377.","journal-title":"Allergic Rhinitis: Rev Jama"},{"issue":"4","key":"822_CR44","doi-asserted-by":"publisher","first-page":"282","DOI":"10.18176\/jiaci.0649","volume":"31","author":"P Iriarte Sot\u00e9s","year":"2021","unstructured":"Iriarte Sot\u00e9s P, et al. Efficacy and safety of Up-dosing antihistamines in chronic spontaneous urticaria: a systematic review of the literature. J Investig Allergol Clin Immunol. 2021;31(4):282\u201391.","journal-title":"J Investig Allergol Clin Immunol"},{"key":"822_CR45","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ajem.2021.08.062","volume":"52","author":"A Renko","year":"2022","unstructured":"Renko A, et al. Unintentional cetirizine overdose causing anticholinergic syndrome. Am J Emerg Med. 2022;52:270. e1-270.e3.","journal-title":"Am J Emerg Med"},{"issue":"4","key":"822_CR46","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2165\/00003088-200847040-00001","volume":"47","author":"P Devillier","year":"2008","unstructured":"Devillier P, Roche N, Faisy C. Clinical pharmacokinetics and pharmacodynamics of desloratadine, fexofenadine and levocetirizine: a comparative review. Clin Pharmacokinet. 2008;47(4):217\u201330.","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"822_CR47","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s40265-016-0682-0","volume":"77","author":"K Snidvongs","year":"2017","unstructured":"Snidvongs K, et al. Sedative effects of Levocetirizine: a systematic review and meta-analysis of randomized controlled studies. Drugs. 2017;77(2):175\u201386.","journal-title":"Drugs"},{"issue":"12","key":"822_CR48","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1097\/CM9.0000000000003071","volume":"137","author":"X Chen","year":"2024","unstructured":"Chen X, et al. Efficacy and safety of bilastine vs. levocetirizine for the treatment of chronic idiopathic urticaria: a multicenter, double-blind, double-dummy, phase III, non-inferiority, randomized clinical trial. Chin Med J (Engl). 2024;137(12):1480\u20132.","journal-title":"Chin Med J (Engl)"},{"key":"822_CR49","unstructured":"National Clinical Guideline C. National institute for health and clinical excellence: Guidance, in Sedation in children and young people: Sedation for diagnostic and therapeutic procedures in children and young people. Royal College of Physicians (UK). 2010. Copyright \u00a9 2010, National Clinical Guideline Centre.: London."},{"key":"822_CR50","unstructured":"Li Y, Picheca L. CADTH Rapid Response reports, in Target-controlled infusion with propofol and remifentanil for moderate procedural sedation in medicine and dentistry: a review of clinical effectiveness, Cost-Effectiveness, and guidelines. Canadian Agency for Drugs and Technologies in Health. 2020. Copyright \u00a9 2020 Canadian Agency for Drugs and Technologies in Health.: Ottawa (ON)."},{"issue":"1","key":"822_CR51","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1046\/j.1365-2125.2002.01611.x","volume":"54","author":"JM Gandon","year":"2002","unstructured":"Gandon JM, Allain H. Lack of effect of single and repeated doses of levocetirizine, a new antihistamine drug, on cognitive and psychomotor functions in healthy volunteers. Br J Clin Pharmacol. 2002;54(1):51\u20138.","journal-title":"Br J Clin Pharmacol"},{"key":"822_CR52","unstructured":"Conditions that are associated with Psychomotor hyperactivity. https:\/\/www.ehealthme.com\/symptom\/psychomotor-hyperactivity\/a\/1\/"},{"key":"822_CR53","doi-asserted-by":"publisher","first-page":"p1596828","DOI":"10.1155\/2016\/1596828","volume":"2016","author":"I Melamed","year":"2016","unstructured":"Melamed I, Heffron M. Attention deficit disorder and allergic rhinitis: are they related? J Immunol Res. 2016;2016:p1596828.","journal-title":"J Immunol Res"},{"issue":"2","key":"822_CR54","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/j.1476-5381.2010.00907.x","volume":"161","author":"P van Ruitenbeek","year":"2010","unstructured":"van Ruitenbeek P, Vermeeren A, Riedel WJ. Histamine H1 receptor antagonist cetirizine impairs working memory processing speed, but not episodic memory. Br J Pharmacol. 2010;161(2):456\u201366.","journal-title":"Br J Pharmacol"},{"issue":"2","key":"822_CR55","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1097\/PEC.0000000000001062","volume":"35","author":"IK Sharawat","year":"2019","unstructured":"Sharawat IK, Dawman L. Acute Focal Dystonia after a single dose of oral cetirizine in a 9-Year-old boy. Pediatr Emerg Care. 2019;35(2):e30\u20131.","journal-title":"Pediatr Emerg Care"},{"issue":"4","key":"822_CR56","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1136\/ejhpharm-2021-002774","volume":"30","author":"X Han","year":"2023","unstructured":"Han X, et al. Epileptic convulsions probably induced by desloratadine: a case report. Eur J Hosp Pharm. 2023;30(4):e17.","journal-title":"Eur J Hosp Pharm"},{"issue":"1","key":"822_CR57","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.cll.2006.01.009","volume":"26","author":"B Wills","year":"2006","unstructured":"Wills B, Erickson T. Chemically induced seizures. Clin Lab Med. 2006;26(1):185\u2013209. ix.","journal-title":"Clin Lab Med"},{"issue":"8","key":"822_CR58","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1016\/j.clinthera.2009.08.015","volume":"31","author":"D Singh-Franco","year":"2009","unstructured":"Singh-Franco D, et al. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children. Clin Ther. 2009;31(8):1664\u201387.","journal-title":"Clin Ther"},{"issue":"5","key":"822_CR59","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.braindev.2008.11.010","volume":"31","author":"CM Dub\u00e9","year":"2009","unstructured":"Dub\u00e9 CM, Brewster AL, Baram TZ. Febrile seizures: mechanisms and relationship to epilepsy. Brain Dev. 2009;31(5):366\u201371.","journal-title":"Brain Dev"},{"issue":"1","key":"822_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3345\/kjp.2014.57.1.1","volume":"57","author":"JB Kim","year":"2014","unstructured":"Kim JB. Channelopathies Korean J Pediatr. 2014;57(1):1\u201318.","journal-title":"Channelopathies Korean J Pediatr"},{"issue":"11","key":"822_CR61","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1007\/s40264-021-01106-7","volume":"44","author":"AK Ersb\u00f8ll","year":"2021","unstructured":"Ersb\u00f8ll AK, et al. Desloratadine exposure and incidence of seizure: a nordic post-authorization Safety Study using a new-user Cohort Study Design, 2001\u20132015. Drug Saf. 2021;44(11):1231\u201342.","journal-title":"Drug Saf"},{"issue":"7","key":"822_CR62","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.7150\/ijms.34141","volume":"16","author":"C Teng","year":"2019","unstructured":"Teng C, et al. Torsades De Pointes and QT prolongation associations with antibiotics: a Pharmacovigilance Study of the FDA adverse event reporting system. Int J Med Sci. 2019;16(7):1018\u201322.","journal-title":"Int J Med Sci"},{"issue":"1","key":"822_CR63","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s40268-016-0167-3","volume":"17","author":"RL Nevin","year":"2017","unstructured":"Nevin RL, Leoutsakos JM. Identification of a syndrome class of neuropsychiatric adverse reactions to Mefloquine from Latent Class modeling of FDA adverse event reporting System Data. Drugs R D. 2017;17(1):199\u2013210.","journal-title":"Drugs R D"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-024-00822-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-024-00822-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-024-00822-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T16:14:52Z","timestamp":1734538492000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/s40360-024-00822-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,18]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["822"],"URL":"https:\/\/doi.org\/10.1186\/s40360-024-00822-x","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,18]]},"assertion":[{"value":"18 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors state that no ethical approval was needed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"We confirm that this study is original and not being considered for publication elsewhere. It has not been posted to a preprint server as well.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Submission declaration"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"95"}}